These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 3226955)
1. Regional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects. Jégou S; Javoy-Agid F; Delbende C; Tranchand-Bunel D; Coy DH; Agid Y; Vaudry H Peptides; 1988; 9(4):787-93. PubMed ID: 3226955 [TBL] [Abstract][Full Text] [Related]
2. In vivo studies on the basal and evoked release of cholecystokinin and vasoactive intestinal polypeptide from cat cerebral cortex and periventricular structures. Wang JY; Yaksh TL; Go VL Brain Res; 1983 Nov; 280(1):105-17. PubMed ID: 6652473 [TBL] [Abstract][Full Text] [Related]
3. Concentrations and distribution of vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI) and peptide histidine valine (PHV) in the cerebral cortex and the suprachiasmatic nucleus of the mouse. Mikkelsen JD; Fahrenkrug J Brain Res; 1994 Sep; 656(1):95-107. PubMed ID: 7804850 [TBL] [Abstract][Full Text] [Related]
4. Substance P immunoreactivity in the post-mortem parkinsonian brain. Tenovuo O; Rinne UK; Viljanen MK Brain Res; 1984 Jun; 303(1):113-6. PubMed ID: 6203617 [TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal polypeptide carboxy-terminal fragment, VIP(22-28), and other fragments of VIP, in the central nervous system of the rat. Romualdi P; Rosenberger JG; Gozzini L; Cox BM Peptides; 1989; 10(3):621-6. PubMed ID: 2780421 [TBL] [Abstract][Full Text] [Related]
6. Radioimmunologic localization of vasoactive intestinal polypeptide in hypothalamic and extrahypothalamic sites in the rat brain. Samson WK; Said SI; McCann SM Neurosci Lett; 1979 May; 12(2-3):265-9. PubMed ID: 460720 [TBL] [Abstract][Full Text] [Related]
7. Analysis of peptide histidine-isoleucine/vasoactive intestinal polypeptide-immunoreactive neurons in the central nervous system with special reference to their relation to corticotropin releasing factor- and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus. Hökfelt T; Fahrenkrug J; Ju G; Ceccatelli S; Tsuruo Y; Meister B; Mutt V; Rundgren M; Brodin E; Terenius L Neuroscience; 1987 Dec; 23(3):827-57. PubMed ID: 3125490 [TBL] [Abstract][Full Text] [Related]
8. VIP in the rat brain: evidence for a major pathway linking the amygdala and hypothalamus via the stria terminalis. Roberts GW; Woodhams PL; Bryant MG; Crow TJ; Bloom SR; Polak JM Histochemistry; 1980 Feb; 65(2):103-19. PubMed ID: 7358518 [TBL] [Abstract][Full Text] [Related]
9. The distribution of cholecystokinin and vasoactive intestinal peptide in rhesus monkey brain as determined by radioimmunoassay. Beinfeld MC; Lewis ME; Eiden LE; Nilaver G; Pert CB Neuropeptides; 1983 Jul; 3(5):337-44. PubMed ID: 6621827 [TBL] [Abstract][Full Text] [Related]
10. Regional distribution of vasoactive intestinal peptide immunoreactivity in the brain of salmon, trout and carp. Canciglia P; Martin JL; Bolis CL; Randall D; Magistretti PJ Biol Signals; 1995; 4(2):86-93. PubMed ID: 8590917 [TBL] [Abstract][Full Text] [Related]
11. Characterization and regional distribution of peptides derived from the vasoactive intestinal peptide precursor in the normal human brain. Fahrenkrug J; Emson PC J Neurochem; 1989 Oct; 53(4):1142-8. PubMed ID: 2769258 [TBL] [Abstract][Full Text] [Related]
12. Autoradiographic analysis of the distribution of vasoactive intestinal peptide binding sites in the vertebrate central nervous system: a phylogenetic study. Dietl MM; Hof PR; Martin JL; Magistretti PJ; Palacios JM Brain Res; 1990 Jun; 520(1-2):14-26. PubMed ID: 2169952 [TBL] [Abstract][Full Text] [Related]
13. Effects of chronic atropine administration on regional vasoactive intestinal polypeptide concentrations in rat brain. Petit JM; Denoroy L; Jouvet M Eur J Pharmacol; 1992 Feb; 212(1):79-85. PubMed ID: 1555642 [TBL] [Abstract][Full Text] [Related]
14. Comparative distribution of VIP in the central nervous system of various species measured by a new radioimmunoassay. Németh J; Jakab B; Reglodi D; Lubics A; Józsa R; Hollósy T; Tamás A; Lengvári I; Görcs T; Szolcsányi J Regul Pept; 2002 Nov; 109(1-3):3-7. PubMed ID: 12409208 [TBL] [Abstract][Full Text] [Related]
15. Characterization of neurotensin-like immunoreactivity in human basal ganglia: increased neurotensin levels in substantia nigra in Parkinson's disease. Fernandez A; Jenner P; Marsden CD; De Ceballos ML Peptides; 1995; 16(2):339-46. PubMed ID: 7784265 [TBL] [Abstract][Full Text] [Related]
16. Chronic hypoxia affects peripheral and central vasoactive intestinal peptide-like immunoreactivity in the rat. Poncet L; Denoroy L; Dalmaz Y; Péquignot JM; Jouvet M Neurosci Lett; 1994 Jul; 176(1):1-4. PubMed ID: 7970222 [TBL] [Abstract][Full Text] [Related]
17. Daily variations in concentration of vasoactive intestinal polypeptide immunoreactivity in discrete brain areas of the rat. Morin A; Denoroy L; Jouvet M Brain Res; 1991 Jan; 538(1):136-40. PubMed ID: 2018925 [TBL] [Abstract][Full Text] [Related]
19. Molecular forms of peptide histidine isoleucine-like immunoreactivity in the gastrointestinal tract. Nonequimolar levels of peptide histidine isoleucine and vasoactive intestinal peptide in the stomach explained by the presence of a big peptide histidine isoleucine-like molecule. Yiangou Y; Christofides ND; Blank MA; Yanaihara N; Tatemoto K; Bishop AE; Polak JM; Bloom SR Gastroenterology; 1985 Sep; 89(3):516-24. PubMed ID: 3839480 [TBL] [Abstract][Full Text] [Related]
20. Human brain phenolsulfotransferase. Regional distribution in Parkinson's disease. Baran H; Jellinger K J Neural Transm Park Dis Dement Sect; 1992; 4():267-76. PubMed ID: 1388697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]